Blood components for topical use in tissue regeneration: Evaluation of corneal lesions treated with platelet lysate and considerations on repair mechanisms

Blood Transfusion

Volumn 8, Issue 2, 2010, Pages 107-112

  Geremicca, Walter ^a   Fonte, Carla ^a   Vecchio, Sisto ^b  

^a SIMTI ASP   (Italy)

^b CT ASP   (Italy)

Author keywords

Corneal ulcers; Growth factors; Platelet lysate; Platelet rich plasma

Indexed keywords

ANTIBIOTIC AGENT; ARTIFICIAL TEAR; CYTOKINE; EYE DROPS; GLUCOCORTICOID; GROWTH FACTOR; THROMBOCYTE CONCENTRATE;

ADULT; AGED; ARTICLE; BLOOD COMPONENT; CELL LYSATE; CLINICAL EVALUATION; CLINICAL TRIAL; CONTACT LENS; CORNEA LESION; CORNEA ULCER; DISEASE SEVERITY; DRUG CONTAMINATION; DRUG FORMULATION; DRUG PURITY; FROZEN SECTION; HUMAN; KERATITIS; KERATOPATHY; MAJOR CLINICAL STUDY; NEUROTROPHIC KERATITIS; PATIENT SATISFACTION; POSTHERPETIC UVEITIS; RISK FACTOR; RISK REDUCTION; THROMBOCYTE RICH PLASMA; TISSUE REGENERATION; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; ULCER HEALING; UVEITIS;

ADMINISTRATION, TOPICAL; ADULT; AGED; BLOOD PLATELETS; CELL EXTRACTS; CORNEA; CORNEAL ULCER; EPITHELIUM, CORNEAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INSTILLATION, DRUG; MALE; MICROSCOPY, CONFOCAL; MIDDLE AGED; OPHTHALMIC SOLUTIONS; REGENERATION; RETROSPECTIVE STUDIES;

EID: 77953509456     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: 10.2450/2009.0091-09     Document Type: Article

References (56)

1. Featherstone C. Fibrin sealants for haemostasis and drug delivery. Lancet 1997; 349: 334.
2. Martinowitz U, Spotnitz WD. Fibrin tissue adhesives. Thromb Haemost 1997; 78: 661-6.
3. Patrlj L, Kocman M, Martinac M, et al. Fibrin glue-antibiotic mixture in the treatment of anal fistulae: experience with 69 cases. Dig Surg 2000; 17: 77-80. (Pubitemid 30133129)
4. Kitajiri S, Tabuchi K, Hiraumi H, Kaetsu H, et al. Relief of post-tonsillectomy pain by release of lidocaine from fibrin glue. Laryngoscope 2001; 111: 642-4. (Pubitemid 32295277)
5. Ochsner MG. Fibrin solutions to control hemorrhage in the trauma patient. J Long Term Eff Med Implants 1988; 8: 161-73.
6. Jackson MR. Fibrin sealants in surgical practice: an overview. Am J Surg 2001; 182: 1S-7S.
7. Kumar U, Albala DM. Fibrin glue applications in urology. Cur Urol Rep 2001; 2: 79-82.
8. Bensaid W, Triffitt JT, Blanchat C, et al. A biodegradable fibrin scaffold for mesenchymal stem cell transplantation. Biomaterials 2003; 24: 2497-502. (Pubitemid 36407666)
9. Marx RE, Carlson ER, Eichstaedt RM, et al. Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol 1998; 85: 638-46.
10. American Academy of Perioodontol Position Paper. The potential role of growth and differentiation factors in periodontal regeneration. J Periodontol 1996; 67: 543-53.
11. Banoth S, Alex JC. Current applications of platelet-gels in facial plastic surgery. Facial Plast Surg 2002; 18: 27-32.
12. Froum SI, Wallace SS, Tarnow DP, et al. Effect of platelet rich plasma on bone growth and osseointegration in human maxillary sinus grafts: three bilateral case reports. Int J Periodont Restor Dent 2002; 22: 45-53.
13. Sacchi MC, Bellanda M, Vercellotti T. Il concentrato piastrinico in chirurgia orale e implantare. Dent Mod 2000; 1: 69-78.
14. Grageda E, Loazada JL, Boyne PJ, et al. Bone formation in the maxillary sinus by using platelet-rich plasma: an experimental study in sheep. J Oral Implantol 2005; 31: 2-17.
15. Fontana S, Olmedo DG, Linares JA, et al. Effect of platelet-rich plasma on the peri-implant bone response: an experimental study. Implant Dent 2004; 13: 73-8. (Pubitemid 40340563)
16. Giannobile WV, Somerman MJ. Growth and amelogenin-like factors in periodontal wound healing. A systematic review. Ann Periodontol 2003; 8: 193-204.
17. Weibrich G, Hansen T, Kleis W, et al. Effect of platelet concentration in platelet rich-plasma on peri-implant bone regeneration. Bone 2004; 34: 665-71.
18. Dean H, Whintman DDS, Ronald L. Platelet gel: an autologous alternative to fibrin glue with applications in oral and maxillofacial surgery. J Oral Maxillofac Surg 1997; 55: 1294-9.
19. Robson MC, Phillips LG, Thomason A, et al. Platelet-derived growth factor BB for the treatment of chronic pressure ulcers. Lancet 1992; 339: 23-5.
20. Snyder EL, Calhoun BC. Topical platelet growth factor therapy: of lotions and potions. Transfusion 2001; 41: 1186-9.
21. Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med 1999; 341: 738-46.
22. Crovetti G, Martinelli G, Issi M, et al. Platelet gel for healing cutaneous chronic wounds. Transf Apheresis Sci 2004; 30: 145-51.
23. Caloprisco G, Borean A. Chronic skin ulcers: a regenerative stimulation by topical hemotherapy. Int J Artific Org 2004; 27: 816-7.
24. Senet P, Bon FX, Benbunan M, et al. Randomized trial and local biological effect of autologous platelets used as adjuvant therapy for chronic venous leg ulcers. J Vasc Surg 2003; 38: 1342-8.
25. Borzini P, Mazzucco L, Panizza R, et al. Regarding "Randomized trial and local biological effect of autologous platelets used as adjuvant therapy for chronic venous leg ulcers". J Vasc Surg 2004; 39: 1146-7.
26. Slater M, Patava J, Kingham K, Mason RS. Involvement of platelets in stimulating osteogenic activity. J Orthop Res 1995; 13: 655-63.
27. Rughetti A, Flamini S, Colafarina O, et al. Closed surgery: autologous platelet gel for the treatment of pseudoarthrosis. Blood Transf 2004; 2: 37-43.
28. Mazzucco L, Medici D, Serra M, et al. The use of autologous platelet gel to treat difficult-to-heal wounds: a pilot study. Transfusion 2004; 44: 1013-8. (Pubitemid 38823807)
29. Ross R. Platelet-derived growth factor. Annu Rev Med 1987; 38: 71-9.
30. Antoniades HN, Williams LT. Human platelet-derived growth factor: structure and functions. Fed Proc 1983; 42: 2630-4.
31. Manhard PS, Codispoti M. The role of fibrin sealants in hemostasis. Am J Surg 2001; 181: 21S-28S.
32. Borzini P, Mazzucco L. Tissue regeneration and in loco administration of platelet derivatives: clinical outcome, heterogeneous products, and heterogeneity of the effector mechanisms. Transfusion 2005; 45: 1759-67. (Pubitemid 43923903)
33. Zimmermann R, Jakubietz R, Jakubietz M, et al. Different preparation methods to obtain platelet component as a source of growth factors for local application. Transfusion 2001; 41:1217-24. (Pubitemid 33000956)
34. Mazzucco L, Balbo V, Cattana E, Borzini P. PRP and platelet gel preparation using Plateltex®. Vox Sang 2008; 94: 202-8.
35. Zimmermann R, Arnold D, Strasser E, et al. Sample preparation technique and white cell content influence the detectable levels of growth factors in platelet concentrates. Vox Sang 2003; 85: 283-9. (Pubitemid 37522602)
36. Caloprisco G, Barbone E, Borean A, et al. Local haemotherapy of chronic skin ulcers with leucocyte-platelet gel produced from blood components obtained with a cell separator. Blood Transf 2004; 2: 44-54.
37. O'Neill EM, Zalewski WM, Eaton LJ, et al. Autologous platelet-rich plasma isolated using the Haemonetics Cell Saver 5 and Haemonetics MCS+ for the preparation of platelet gel. Vox Sang 2001; 81: 172-5.
38. Weibrich G, Kleis WK, Hanfer G, et al. Growth factor levels in platelet-rich plasma and correlation with donor age, sex, and platelet count. J Craniomaxillofac Surg 2002; 30: 97-102. (Pubitemid 34846492)
39. Dell'Orso L, Rughetti A, Dolo V. Gli standard di prodotto [abstract]. Blood Transf 2008; 6: S23-5.
40. Yazawa M, Ogata H, Nakajima T, et al. Basic studies on the clinical applications of platelet-rich plasma. Cell Transplant 2003; 12: 509-18. (Pubitemid 36993194)
41. Korobelnik JF. Autologous platelet concentrate as an adjunct in macular hole healing. Ophthalmology 1966; 103: 590-4.
42. Gehring S, Hoerauf H, Laqua H, et al. Preparation of autologous platelets for the ophthalmologic treatment of macular holes. Transfusion 1999; 39: 144-8. (Pubitemid 29085134)
43. Vote BJ, Membrey WL, Casswell AG. Autologous platelets for macular hole surgery: the Sussex Eye Hospital experience. Clin Experiment Ophthalmol 2004; 32: 472-7.
44. Wachtlin J, Jandeck C, Potthofer S, et al. Long-term results following pars plana vitrectomy with platelet concentrate in pediatric patients with traumatic macular hole. Am J Ophthalmol 2003; 136: 197-9.
45. Hartiwing D, Harloff S, Liu L, et al. Epitheliotrophic capacity of growth factor preparation produced from platelet concentrates on corneal epithelial cells: a potential agent for the treatment of ocular surface defects? Transfusion 2004; 44: 1724-31.
46. Kaplan DR, Chao FC, Stiles CD, et al. Platelet a-granules contain a growth factor for fibroblasts. Blood 1979; 53: 1043-52.
47. Miyazono K, Takaku F. Platelet-derived growth factors. Blood Rev 1989; 3: 269-76.
48. Mohan S, Baylink DJ. Bone growth factors. Clin Orthop 1991; 263: 30-48.
49. Canalis E. Clinical review 35: growth factors and their potential clinical value. J Clin Endocrinol Metabol 1992; 75: 1-4.
50. Tezono K, Sarker KP, Kikuchi H, et al. Bioactivity of the vascular endothelial growth factor trapped in fibrin clots: production of IL-6 and IL-8 in monocytes by fibrin clots. Haemostasis 2001; 31: 71-9.
51. D'Agostino E, Fratellanza G, Caloprisco G, et al. Effetto del gel piastrinico sulla proliferazione cellulare in vitro. La Trasf del Sangue 2000; 47: 429-33.
52. Borzini P, Mazzucco L, Cattana L. Platelet gel: clinical use and unanswered questions. Blood Transfus 2004; 2: 10-4.
53. Liu X, Sun Y, Costantinescu SN, et al. Transforming growth factor â-induced phosphorylation of growth inhibition and transcriptional induction in epithelial cells. Proc Natl Acad Sci USA 1997; 94: 10699-74.
54. Rosenwald IB, Pechet L, Han A, et al. Expression of translation initiation factors elF-2E and elF-2alpha and a potential physiologic role of continuous protein synthesis in human platelets. Thromb Haemost 2001; 85: 142-51.
55. Martineau I, Lacoste E, Gagnon G. Effects of calcium and thrombin on growth factor release from platelet concentrates: kinetics and regulation of endothelial cell proliferation. Biomaterials 2004; 25: 4489-502.
56. Gruber R, Jindra C, Kandler B, et al. Proliferation of dental pulp fibroblasts in response to thrombin involves mutagen-activated protein kinase signaling. Int Endod J 2004; 37: 145-50.